CompaniesByCap
AUPH
Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ · Healthcare

Aurinia Pharmaceuticals Inc. Income Statement 2018–2025

Income StatementBalance SheetCash Flow
Dec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenues
Revenue283.1M235.1M175.5M134.0M45.6M50.1M318,000463,000
Gross Profit250.4M206.9M161.4M128.4M44.5M50.1M318,000
Profitability
Operating Income104.9M-4.7M-91.7M-111.5M-180.7M-104.3M-90.9M-55.2M
EBITDA124.4M14.8M-80.0M-108.8M-178.0M-102.9M
Net Income287.2M5.8M-78.0M-108.2M-181.0M-102.7M-88.4M-53.1M
Per Share Data
EPS (diluted)
Shares Outstanding (dil.)139M146M143M142M129M118M112M86M

Aurinia Pharmaceuticals Inc. Income Statement — FAQ

Aurinia Pharmaceuticals Inc. (AUPH) income statement over the last 8 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see AUPH's income statement history?

The chart and table above show Aurinia Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.